INTRODUCTION
Hereditary hemochromatosis is a disorder of iron metabolism characterized by the accumulation of large amounts of iron in the parenchymal cells of the liver, cirrhosis, diabetes, heart disease, and arthropathies. The genetic linkage of this disease to HLA-A and HLA-B has been recognized for over 20 years (1) . However, it was only in 1996 that the HLA-H gene was identified and the mutations that give rise to HLA-linked hemochromatosis were found (2) .
Most patients with hereditary hemochromatosis are homozygous for the 845G->A (845A; C282Y) mutation of the HLA-H gene. In addition, some patients are compound heterozygotes for this mutation and a 187C->G (187G; H63D) mutation of the HLA-H gene. In most studies, however, 10% to 15% of Caucasian patients have ferrin) gene of 10, 7 , and 5 hemochromatosis patients, respectively, selecting those who were not homozygous for the 845A(C282Y) mutation. The number of chromosomes at risk studied were 18 for HLA-H, 14 for ,B-2-microglobulin, and 10 for calreticulin. Results: We detected 3 new intronic polymorphisms in the HLA-H gene, each a point mutation. Some differences from published sequences of 13-2-microglobulin and calreticulin were documented, but these were unifornly present in all samples. Conclusions: The lack of additional mutations in the HLA-H gene is remarkable, and we speculate that the C282Y mutation may be a gain-of-function change.
neither of these genotypes (2) (3) (4) (5) . Among Asian patients with hemochromatosis none have been found to have the C282Y mutation (3) .
The cause of hemochromatosis in patients without the C282Y/C282Y or C282Y/H63D genotypes is unclear. It is possible that they have other mutations in HLA-H, although Feder et al., in their original report (2) , found none. The cysteine --tyrosine substitution at amino acid 282 is believed to impair f32-microglobulin binding of HLA-H, and it has been found that f32-microglobulin-deficient mice accumulate iron. Indeed, it has been suggested that they represent an animal model of human hemochromatosis (6, 7) . Another protein, calreticulin, is also of interest. This protein not only binds to HLA class 1 molecules (8) but is thought to be identical to mobilferrin, an iron transport protein (9) . Accordingly, we have examined the DNA sequences of HLA-H, f32-microglobulin, and calreticulin in a group of hemochromatosis patients, most of whom lacked the typical hemochromatosis genotype. 
RESULTS

HLA-H
The entire coding region of the HLA-H gene of 10 patients was sequenced. Included were 8 patients with the normal 845G/845G genotype and 2 patients who were heterozygous for the 845A (C282Y) mutation, both of whom were compound heterozygotes for 187G (H63D). All of the coding region except for a portion of exon 3 was sequenced in an additional patient with the normal 845G/845G genotype.
No additional mutations were found in the coding region of HLA-H. However, three polymorphic sites were detected in introns 2, 4, and 5. The relevant sequences are shown in Fig. 1 . In studying a large number of normal subjects and patients with hemochromatosis, 6 of the 8 possible haplotypes created by these diallelic sites have been identified (data not shown).
18-2-Microglobulin
The entire coding region of the 3-2-microglobu- Apart from these differences, which were found in all samples, the /3-2 microglobulin sequence was identical to the sequences deposited in GenBank. Accordingly, it appears that there were no mutations that could account for iron storage disease in these samples.
Calreticulin (mobilferrin)
The entire coding region and the promoter of the calreticulin gene of 5 patients was sequenced. Included were 3 patients with the normal 845G/ 845G genotype and 2 patients who were heterozygous for the 845A (C282Y) mutation, one of whom was a compound heterozygote for 187G (H63D). There were three differences in the sequences we obtained from the reference sequence GenBank X59053. We found that nt 165-169 were cccgc instead of gggcg, that a t at nt 201 was deleted and that two g's were found at nt 368 rather than the one given in the GenBank file. However, two other GenBank sequences, X85727 and AD000092, agreed with the sequence that we found. Moreover, we sequenced the promoter region from an additional 8 hemochromatosis patients with the 845G/ 845G genotype and from 3 normal subjects, finding the same sequence. Therefore, it as apparent that no mutations that could account for hemochromatosis were found in any of the samples examined.
DISCUSSION
The discovery of the HLA-H gene on chromosome 6 is a major advance in the understanding of hemochromatosis. (11) (12) (13) (14) . However, Feder et al. (2) found only the C282Y and H63D mutations to be associated with hereditary hemochromatosis; they were unable to find any other mutations in the 30 patients that they studied who were not homozygous for the C282Y. These were our finding, too, in the 10 patients with 18 chromosomes at risk that we studied. We are surprised at this finding, but with total lack of information regarding the mechanism by which the homozygous C282Y substitution causes increased iron absorption and of how the heterozygote for this mutation is complemented by the H63D substitution, one can only speculate about the lack of other mutations in HLA-H in hemochromatosis patients. Possibly, the C282Y mutation produces a gain-of-function rather than a loss-of-function. If this were the case, other mutations that prevented synthesis of HLA-H might not complement this mutation or cause a similar phenotype. The sickle cell mutation can be regarded as an example of such a gain-of-function mutation. Of the hundreds of mutations known to exist in the hemoglobin (3-chain gene, it is only the glu->val substitution in codon 6 that supports sickling. The putative, partially dominant nature of the C282Y mutation (15, 16 ) fits a gain-of-function model, but data concerning the phenotype of "heterozygotes" will need to be re-evaluated to separate compound heterozygotes for the H63D mutation from simple heterozygotes.
Since HLA class 1 molecules associate with other proteins during transport to the membrane, it seemed possible that mutations of such molecules might create phenocopies of the HLA-H mutations. The most attractive candidates for such mutations are 3-2-microglobulin and calreticulin. f3-2-microglobulin seems to be an outstanding candidate because it is believed to associate with HLA-H (2) and because targeted disruption of the murine gene is associated with iron storage (6) . Calreticulin is known to associate with many proteins, including HLA class I molecules (8) , but our particular interest in this molecule is based on the demonstration that the iron transport protein mobilferrin seems to be identical with calreticulin (9) . A number of dif-ferences were found in the sequences of these genes from those deposited in GenBank. However, these were found in the homozygous form in all samples examined. Only a few of the differences were in coding regions, and in these we found other GenBank sequences that were identical to ours. Thus, we concluded that there were no significant mutations in either of these genes in any of the hemochromatosis patients studied.
In sequencing the HLA-H gene we found three new polymorphic sites. All of these are intronic and are unlikely by their nature and location to cause abnormalities in splicing. We have detected 6 haplotypes of HLA-H. If the 845A and 187G hemochromatosis mutations are included, 8 haplotypes of the HLA-H gene can now be differentiated. Because these are diallelic markers, they may prove to be useful in genetic studies of this portion of chromosome 6.
